Book Excerpt from Rise of the Necrofauna

In chapter 4, “Why Recreate the Woolly Mammoth?” author Britt Wray explores the social consequences of bringing an iconic species back from extinction.

Written byBritt Wray
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

GREYSTONE BOOKS, OCTOBER 2017People are often willing to pay for something that they think is cool: a flashy convertible, a table at a Michelin-starred restaurant, an overnight stay at an exclusive hotel. But what does it mean when the cool thing is a sentient being? What unexpected forms of commodification might that create? Who profits from making its coolness available? And what happens if it goes out of style?

When considering de-extinction’s potential applications, conservation consultant Kent Redford and colleagues write, “The work will attract funding, inform science, help develop techniques useful in other fields, and provide an example of synthetic organisms that have public appeal.” But that already raises an ethical issue: Should we be promoting the public appeal of synthetic organisms when we could be working harder to increase the public appeal of unmodified creatures that are still around and that face threats in the wild? Are these two things mutually exclusive? Or would it be a mistake to think that they are?

In 2015, Jurassic World, the fourth film in the Jurassic Park series, earned over $200 million at the U.S. box office on opening weekend. In 1993, the original film’s ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies